chorea. The disease was named after a young physician, George Huntington, who in 1872 described the spasmodic and uncoordinated limb movement (chorea) afflicting a handful of families of English descent living in a region of Long Island, New York. He had first encountered these patients when he was just 8 years old, accompanying his father and grandfather on medical rounds. For more than a century, the disease has also erroneously been referred to as 'Huntingdon's disease'.
What are the symptoms? The disease is characterized by involuntary movements, severe emotional disturbance and cognitive decline. It usually strikes in mid-adulthood and progresses inexorably until death occurs ten to twenty years later. The disease, which affects about 1 in 10,000 people, is a dominantly inherited trait. What causes the disease? In common with genes involved in a number of neurodegenerative diseases, the Huntington's disease gene contains a triplet repeat sequence (CAG) that encodes a run of glutamine residues in the corresponding protein.
Healthy people have about 35 CAG repeats in this gene but expansions above this limit, sometimes to more than 100, are invariably associated with the disease. In general, the longer the repeat, the earlier the age of onset.
What is known about huntingtin? Not much, other than that it is a large protein (about 350 kDa), widely expressed and essential for mouse embryonic development. The recent identification of proteins that interact with huntingtin specifically and in a glutamine-dependent manner should shed some light on this. What is clear is that the increased run of glutamines causes the mutant huntingtin protein to form aggregates in and around the nucleus in certain neurons. The pathological significance of this is borne out by similar observations in other triplet repeat diseases, including spinocerebellar ataxia. 
